The ARK Genomic Revolution ETF's ("Fund") investment objective is long -term growth of capital.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | 10X GENOMICS INC CL A COM | — | 9.3947% |
| 2 | TWIST BIOSCIENCE CORP COM | — | 7.7294% |
| 3 | TEMPUS AI INC CL A | — | 6.5616% |
| 4 | CRISPR THERAPEUTICS AG NAMEN AKT | — | 6.2854% |
Last synced Oct 27, 2026, 6:25 AM · Price and AUM from Yahoo Finance · Holdings from SEC N-PORT filings
| 5 | PERSONALIS INC COM | — | 5.4745% |
| 6 | ABSCI CORP COM | — | 5.1399% |
| 7 | GUARDANT HEALTH INC COM | — | 4.7423% |
| 8 | ILLUMINA INC COM | — | 4.7389% |
| 9 | ELI LILLY & COMPANY COM | — | 4.6848% |
| 10 | CAREDX INC COM | — | 4.2990% |
| 11 | NATERA INC COM | — | 4.1292% |
| 12 | BEAM THERAPEUTICS INC COM | — | 3.7771% |
| 13 | COMPASS PATHWAYS PLC SPONSORED ADS | — | 3.2535% |
| 14 | RECURSION PHARMACEUTICALS INC CL A | — | 2.6275% |
| 15 | ADAPTIVE BIOTECHNOLOGIES CORP COM | — | 2.5723% |
| 16 | VERACYTE INC COM | — | 2.5465% |
| 17 | NURIX THERAPEUTICS INC COM | — | 2.5071% |
| 18 | BUTTERFLY NETWORK INC COM CL A | — | 2.1783% |
| 19 | SCHRODINGER INC COM | — | 1.9859% |
| 20 | GENEDX HOLDINGS CORP COM CL A | — | 1.8688% |
| 21 | INTELLIA THERAPEUTICS INC COM | — | 1.8292% |
| 22 | IONIS PHARMACEUTICALS INC COM | — | 1.7674% |
| 23 | ALAMAR BIOSCIENCES INC COMMON STOCK | — | 1.5588% |
| 24 | PRIME MEDICINE INC COM | — | 1.4089% |
| 25 | GENERATE BIOMEDICINES INC COM SHS | — | 1.1129% |
| 26 | ARCTURUS THERAPEUTICS HOLDINGS INC COM | — | 1.0139% |
| 27 | CERUS CORP COM | — | 0.9973% |
| 28 | 908 DEVICES INC COM | — | 0.9801% |
| 29 | PACIFIC BIOSCIENCES OF CALIFORNIA INC COM | — | 0.9557% |
| 30 | ATAIBECKLEY INC COM SHS | — | 0.7582% |
| 31 | SCRIBE THERAPEUTICS INC COM | — | 0.4405% |
| 32 | QUANTUM-SI INC COM CL A | — | 0.3093% |
| 33 | GOLDMAN FS TRSY OBLIG INS | — | 0.1806% |